University of Oxford researchers are due to start dosing healthy volunteers in a clinical trial of their coronavirus vaccine ChAdOx1 nCoV-19 this week, which is already in full production.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,